fda4 min read
FDA Orders New Vision Loss Warning for Ozempic and Other GLP-1s
Health regulators have found a consistent link between GLP-1 use and the eye condition NAION.
By Ed CaraGizmodo — AI

Read the full story
Originally published by Gizmodo — AI on Nov 9, 2026.
Comments
Sign in to join the discussion.